Molecular epidemiology of a hepatitis C virus outbreak in a haemodialysis unit

Nephrology Dialysis Transplantation

Volumn 14, Issue 5, 1999, Pages 1188-1194

  Antigoni, Katsoulidou ^a   Paraskevis, Dimitrios ^a   Kalapothaki, Victoria ^a   Arvanitis, Dimitrios ^b   Karayiannis, Peter ^c   Hadjiconstantinou, Valsamakis ^b   Hatzakis, Angeles ^a   Hatzakis, A ^a   Katsoulidou, A ^a   Psichogiou, M ^a   Vaindirli, E ^a   Vosnidis, G ^d   Boletis, J ^d   Stamatiadis, D ^d   Voudiclari, S ^e   Priftis, Ch ^e   Koulousiou, M ^e   Moutafis, S ^f   Ifandi, K ^f   Thanou, I ^f   Skoutelis, G ^g   Triandafilou, K ^g   Matzaropoulou, M ^g   Hadjiconstantinou, V ^b   Arvanitis, D ^b   Logothetis, E ^b   more..

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b AMALIA FLEMING GENERAL HOSPITAL   (Greece)

^c ST MARY S HOSPITAL   (United Kingdom)

^d LAIKO GENERAL HOSPITAL   (Greece)

^e HIPPOKRATION HOSPITAL   (Greece)

^f Kianous Stavros Clinic   (Greece)

^g Athinalki Clinic   (Greece)

Author keywords

Genotyping; Haemodialysis; Hepatitis C virus; Nosocomial infection; Nucleic acid sequencing; Phylogenetic analysis

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ARTICLE; CLINICAL ARTICLE; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROCONVERSION; VIRUS GENOME; VIRUS TRANSMISSION;

EID: 0344004831     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.5.1188     Document Type: Article

References (49)

1. Esteban JI, Esteban R, Viladomiu L et al. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989; 334: 294-296
2. Schlipköter U, Roggendorf M, Ernst G et al. Hepatitis C virus antibodies in hemodialysis patients. Lancet 1990; 335: 1409
3. Gilli P, Moretti M, Soffritti S et al. Non-A, non-B hepatitis and anti-HCV antibodies in dialysis patients. Int J Artif Organs 1990; 13: 737-741
4. Jeffers LJ, Perez GO, De Medina MD et al. Hepatitis C infection in two urban hemodialysis units. Kidney Int 1990; 38: 320-322
5. Hayashi J, Nakashima K, Kajiyama W et al. Prevalence of antibody to hepatitis C virus in hemodialysis patients Am J Epidemiol 1991; 134: 651-657
6. Ponz E, Campistol JM, Barrera J et al. Hepatitis C virus antibodies in patients on hemodialysis and after kidney transplantation. Transplant Proc 1991; 23: 1371-1372
7. Lin HH, Huang CC, Sheen IS, Lin DY, Liaw YF. Prevalence of antibodies to hepatitis C virus in the hemodialysis unit. Am J Nephrol 1991; 11: 192-194
8. Mondelli MU, Smedile V, Piazza V et al. Abnormal alanine aminotransferase activity reflects exposure to hepatitis C in haemodialysis patients. Nephrol Dial Transplant 1991; 6: 480-483
9. Chan TM, Lok ASF, Cheng IKP. Hepatitis C infection among dialysis patients: A comparison between patients on maintenance haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1991; 6: 944-947
10. Oguchi H, Miyasaka M, Tokunaga S et al. Hepatitis virus infection (HBV and HCV) in eleven Japanese hemodialysis units. Clin Nephrol 1992; 38: 36-43
11. Muller GY, Zabaleta ME, Arminio A et al. Risk factors for dialysis-associated hepatitis C in Venezuela. Kidney Int 1992; 41: 1055-1058
12. Mondelli MU, Cristina G, Pazza V, Cerino A, Villa G, Salvadeo A. High prevalence of antibodies to hepatitis C virus in hemodialysis units using a second generation assay. Nephron 1992; 61: 350-351
13. Chauveau P, Courouce AM, Lemarec N, et al. Antibodies to hepatitis C virus by second generation test in hemodialyzed patients. Kidney Int 1993; 43 [Suppl 41]: S149-S152
14. Knudsen F, Wantzin P, Rasmussen K et al. Hepatitis C in dialysis patients: relationship to blood transfusions, dialysis and liver disease. Kidney Int 1993; 43: 1353-1356
15. Dussol B, Berthèzene P, Brunet P, Roubicek C, Berland Y. Hepatitis C virus infection among chronic dialysis patients in the south of France: A collaborative study. Am J Kidney Dis 1995; 25: 399-404
16. Yamaguchi K, Nishimura Y, Fukuoka N et al. Hepatitis C virus antibodies in haemodialysis patients. Lancet 1990; 335: 1409-1410
17. Calabrese G, Vagelli G, Guaschino R, Gonella M. Transmission of anti-HCV within the household of haemodialysis patients. Lancet 1991; 338: 1466-1467
18. Giammaria U, De Meo F, Acitelli S et al. HCV infection in hemodialyzed patients: incidence and correlation with dialysis age. Nephron 1992; 61: 335-336
19. Cantù P, Mangano S, Masini M, Limido A, Crovetti G, De Fillipo C. Prevalence of antibodies against hepatitis C virus in a dialysis unit. Nephron 1992; 61: 337-338
20. Jadoul M, Cornu C, Van Ypersele De Strihou C. Incidence and risk factors for hepatitis C seroconversion in hemodialysis: A prospective study. Kidney Int 1993; 44: 1322-1326
21. Allander T, Medin C, Jacobson SH, Grillner L, Persson MAA. Hepatitis C transmission in a haemodialysis unit: Molecular evidence for spread of virus among patients not sharing equipment. J Med Virol 1994; 43: 415-419
22. Sampietro M, Badalamenti S, Salvadori S et al. High prevalence of a rare hepatitis C virus in patients treated in the same hemodialysis unit: Evidence for nosocomial transmission of HCV. Kidney Int 1995; 47: 911-917
23. Stuyver L, Claeys H, Wyseur A et al. Hepatitis C in a hemodialysis unit: Molecular evidence for nosocomial transmission. Kidney Int 1996; 49: 889-895
24. Olmer M, Bouchouareb D, Zandotti C, De Micco P, De Lamballerie X. Transmission of the hepatitis C virus in an hemodialysis unit: evidence for nosocomial infection. Clin Nephrol 1996; 47: 263-270
25. Zeuzem S, Scheuermann EH, Waschk D et al. Phylogenetic analysis of hepatitis C virus isolates from hemodialysis patients. Kidney Int 1996; 49: 896-902
26. De Lamballerie X, Olmer M, Bouchouareb D, Zandotti C, De Micco Ph. Nosocomial transmission of hepatitis C in hemodialysis patients. J Med Virol 1996; 49: 296-302
27. ™ HCV) for detection of hepatitis C virus. Z Gastroenterol 1994; 32: 342-347
28. Stuyver L, Rossau R, Wyseur A et al. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 1993; 74: 1093-1102
29. Simmonds P, Holmes EC, Cha TA et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993; 74: 2391-2399
30. Enomoto N, Takada A, Nakao T, Date T. There are two major types of hepatitis C virus in Japan. Biochem Biophys Res Commun 1990; 170: 1021-1025
31. Choo QL, Kuo G, Weiner AJ, Orerby LR, Bradly DW, Houghton M. Isolation of a cDNA clone derived from a blood borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-362
32. Choo QL, Richman KH, Han JH et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 1991; 88: 2451-2455
33. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989; 339: 237-238
34. Higgins DG. and Sharp PM. Fast and sensitive multiple sequence alignments on a microcomputer. Comput Applic Biosci 1989; 5: 151-153
35. Felsenstein J. PHYLIP (Phylogeny Inference Package version 3.5c edn). Department of Genetics, University of Washington, Seattle, USA, 1993
36. Power JP, Lawlor E, Davidson F, Holmes EC, Yap PL, Simmonds P. Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin. Lancet 1995; 345: 1211-1213
37. Féray C, Samuel D, Thiers V et al. Reinfection of liver graft by a hepatitis C virus after liver tranplantation. J Clin Invest 1992; 89: 1361-1365
38. Weiner AJ, Thaler MM, Crawford K et al. A unique, predominent hepatitis C virus variant found in an infant born to a mother with multiple variants. J Virol 1993; 67: 4365-4368
39. Suzuki K, Mizokami M, Lau JYN et al. Confirmation of hepatitis C virus transmission through needlestick accidents by molecular evolutionary analysis. J Infect Dis 1994; 170: 1575-1578
40. Ohto H, Terazawa S, Sasaki Nobuh et al. Transmission of hepatitis C virus from mothers to infants. N Engl J Med 1994; 330: 744-750
41. Allander T, Gruber A, Naghavi M et al. Frequent patient-to-patient transmission of hepatitis C virus in a hematology ward. Lancet 1995; 345: 603-607
42. Esteban JI, Gómez J, Martell M et al. Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med 1996; 334: 555-560
43. Aizaki H, Saito A, Kusakawa I et al. Mother-to-child transmission of a hepatitis C virus variant with an insertional mutation in its hypervariable region. J Hepatol 1996; 25: 608-613
44. Ou CY, Ciesielsky CA, Myers G et al. Molecular epidemiology of HIV transmission in a dental practice. Science 1992; 256: 1165-1171
45. Holmes EC, Leigh Brown AJ, Simmonds P. Sequence data as evidence. Nature 1993; 364: 766
46. McCruden EAB, Munro J, King B, Fitzpatrick S, Briggs JD. Patient-to-patient transmission of hepatitis C virus. Lancet 1995; 345: 1443-1444
47. Medin C, Allander T, Roll M, Jacobson SH, Grillner L. Seroconversion to hepatitis C virus in dialysis patients: a retrospective and prospective study. Nephron 1993; 65: 40-45
48. Oliva JA, Maymo RM, Carrio J, Delgado O, Mallafre JM. Late seroconversion of C virus markers in hemodialysis patients. Kidney Int 1993; 43 [Suppl 41]: S153-S156
49. Psichogiou M, Katsoulidou A, Vaindirli E, Francis B, Lee SR, Hatzakis A. Immunologic events during the incubation period of hepatitis C virus infection: the role of antibodies to E2 glycoprotein. Transfusion 1997; 37: 858-862